2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Glenn N. Levine, Eric R. Bates, John A. Bittl, Ralph G. Brindis, Stephan D. Fihn, Lee A. Fleisher, Christopher B. Granger, Richard A. Lange, Michael J. Mack, Laura Mauri, Roxana Mehran, Debabrata Mukherjee, L. Kristin Newby, Patrick T. O'Gara, Marc S. Sabatine, Peter K. Smith, Sidney C. Smith, Jonathan L. Halperin, Glenn N. Levine, Sana M. Al-KhatibKim K. Birtcher, Biykem Bozkurt, Ralph G. Brindis, Joaquin E. Cigarroa, Lesley H. Curtis, Lee A. Fleisher, Federico Gentile, Samuel Gidding, Mark A. Hlatky, John S. Ikonomidis, José A. Joglar, Susan J. Pressler, Duminda N. Wijeysundera

    Research output: Contribution to journalArticlepeer-review

    153 Scopus citations
    Original languageEnglish (US)
    Pages (from-to)1243-1275
    Number of pages33
    JournalJournal of Thoracic and Cardiovascular Surgery
    Volume152
    Issue number5
    DOIs
    StatePublished - Nov 1 2016

    Keywords

    • AHA
    • P2Y inhibitor
    • Scientific Statements
    • acute coronary syndrome
    • aspirin
    • coronary artery disease
    • coronary stents
    • dual antiplatelet therapy (DAPT)
    • focused update
    • stable ischemic heart disease

    ASJC Scopus subject areas

    • Surgery
    • Pulmonary and Respiratory Medicine
    • Cardiology and Cardiovascular Medicine

    Cite this